Cytokine-release syndrome: general risk-factor modification--preparation of high-risk patients for use of OKT3

Transplant Proc. 1993 Apr;25(2 Suppl 1):60-2.

Authors

J Radhakrishnan¹, D J Cohen

Affiliation

¹ Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.

PMID: 8465429

No abstract available

Publication types

Review

MeSH terms

Central Nervous System Diseases / etiology*
Central Nervous System Diseases / immunology
Cytokines / metabolism
Cytokines / physiology*
Humans
Muromonab-CD3 / adverse effects
Muromonab-CD3 / therapeutic use*
Risk Factors
Syndrome
T-Lymphocytes / immunology

Substances

Cytokines
Muromonab-CD3